Anti-HSV1 + HSV2 gB antibody [10B7] and 3 more items

The University of Virginia awarded contract A207_PO-0475698 to Epitomics Inc on September 2, 2026, for the procurement of specialized monoclonal antibodies targeting herpes simplex virus (HSV) proteins. The contract encompasses four distinct antibody products with a cumulative value of $1,866.15. Deliveries are designated for Sarah Dremel at the University of Virginia in Virginia. The line items include anti-HSV1 and HSV2 glycoprotein B antibody [10B7] at $346.50, anti-HSV1 and HSV2 glycoprotein D antibody [2C10] at $445.50, anti-HSV1 and HSV2 antibody at $524.70, and anti-HSV1 glycoprotein H antibody [BBH1] at $549.45.

This procurement represents a research-focused acquisition in which the University of Virginia contracted with Epitomics Inc for the supply of immunological reagents used in virology research applications. The contract documents indicate a single unit quantity for each antibody product, suggesting this award fulfills a specific research requirement. No separate annual value or extended contract period is specified in the available documentation, indicating this appears to be a discrete purchase order for immediate delivery of the enumerated antibody products.